BIIB Financial Facts
Diluted earnings per share attributable to Biogen Idec Inc.: 219.4MProduct: 2.54B
See Full Income Statement
Treasury stock, at cost: -2.61B
Commitments and contingencies (Notes 2, 11, 16, 18 and 20): 0
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 7/23/24 *Est. | EPS Growth Rate | +7.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.8% | Revenue Growth Rate | -6.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/26/10  |
 |
Q310 | $1.35 | $1.23 | +$0.12 | N/A | N/A | N/A |  | | Details |
| 2/1/11 |
|
Q410 | $1.42 | $1.23 | +$0.19 | $1.22B | $1.17B | = | | | Details |
| 7/26/11 |
|
Q211 | $1.36 | $1.37 | -$0.01 | $1.21B | $1.18B | = | | | Details |
| 4/21/11 |
|
Q111 | $1.43 | $1.41 | +$0.02 | $1.2M | $1.18B | = | | | Details |
| 1/28/13 |
|
Q412 | $1.40 | $1.46 | -$0.06 | $1.4B | $1.38B |  |
| | Details |
| 5/1/12 |
|
Q112 | $1.40 | $1.48 | -$0.08 | $1.29B | $1.31B | = | | | Details |
| 1/31/12 |
|
Q411 | $1.51 | $1.49 | +$0.02 | $1.3B | $1.29B | = | | | Details |
| 10/28/11 |
|
Q311 | $1.61 | $1.53 | +$0.08 | $1.31B | $1.27B | = | | | Details |
